Literature DB >> 12944708

HLA typing and Parkinson's disease.

J B Lampe1, G Gossrau, B Herting, A Kempe, U Sommer, M Füssel, M Weber, R Koch, H Reichmann.   

Abstract

Idiopathic Parkinson's disease (IPD) is a neurodegenerative disorder of unknown aetiology. Several antigens have been associated with IPD using serological methods. We systematically analysed HLA class I and II alleles in 45 German Caucasian IPD patients using sequence-specific oligonucleotides and sequence-specific primer technology. Applying Bonferroni adjusted p values, we demonstrate a statistically significant increase of the DQB1*06 allele (p = 0.002) in IPD which may indicate an association between IPD and the immune system. Alternatively, HLA alleles might be in linkage disequilibrium with genes located next to the HLA locus. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12944708     DOI: 10.1159/000072500

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  17 in total

1.  Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.

Authors:  Bryan A Bassig; Peter D Inskip; Laurie Burdette; William R Shapiro; Robert G Selker; Howard A Fine; Jay S Loeffler; Peter M Black; Robert Dubrow; Alina V Brenner
Journal:  J Neuroimmunol       Date:  2010-12-30       Impact factor: 3.478

2.  Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson's disease.

Authors:  G Gossrau; B Herting; S Möckel; A Kempe; R Koch; H Reichmann; J B Lampe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

Review 3.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

4.  Human leukocyte antigen variation and Parkinson's disease.

Authors:  Andreas Puschmann; Christophe Verbeeck; Michael G Heckman; Alexandra I Soto-Ortolaza; Timothy Lynch; Barbara Jasinska-Myga; Grzegorz Opala; Anna Krygowska-Wajs; Maria Barcikowska; Ryan J Uitti; Zbigniew K Wszolek; Owen A Ross
Journal:  Parkinsonism Relat Disord       Date:  2011-04-11       Impact factor: 4.891

Review 5.  Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.

Authors:  Ravindran Kumaran; Mark R Cookson
Journal:  Hum Mol Genet       Date:  2015-06-22       Impact factor: 6.150

Review 6.  M1 and M2 immune activation in Parkinson's Disease: Foe and ally?

Authors:  M S Moehle; A B West
Journal:  Neuroscience       Date:  2014-11-25       Impact factor: 3.590

7.  Pharmacogenetic and Association Studies on the Influence of HLA Alleles and Rivastigmine on the Iranian Patients with Late-Onset Alzheimer's Disease.

Authors:  Fatemeh Rezaei Rad; Masood Ghahvechi Akbari; Majid Zamani; Shiva Bayat; Mahdi Zamani
Journal:  Mol Neurobiol       Date:  2021-01-27       Impact factor: 5.590

8.  Genome-wide association study confirms extant PD risk loci among the Dutch.

Authors:  Javier Simón-Sánchez; Jacobus J van Hilten; Bart van de Warrenburg; Bart Post; Henk W Berendse; Sampath Arepalli; Dena G Hernandez; Rob M A de Bie; Daan Velseboer; Hans Scheffer; Bas Bloem; Karin D van Dijk; Fernando Rivadeneira; Albert Hofman; André G Uitterlinden; Patrizia Rizzu; Zoltan Bochdanovits; Andrew B Singleton; Peter Heutink
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

Review 9.  Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells.

Authors:  Hugo González; Francisco Contreras; Rodrigo Pacheco
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-28       Impact factor: 4.147

Review 10.  The role of inflammation in sporadic and familial Parkinson's disease.

Authors:  Michela Deleidi; Thomas Gasser
Journal:  Cell Mol Life Sci       Date:  2013-05-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.